Peptide record

TPDB44230

Antiviral standard
41 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB44230
Antiviral
Anti-infective peptides
AI4AVP Peptipedia
standard
No
A 41-aa standard-residue antiviral peptide sequence curated from AI4AVP and Peptipedia, with an available 3D structural model.
Sequence
EINCTRPNNNTRKSIHIGPGRAFYTTGEIIGDIRQAHCNIS
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C193H312N64O61S2
LMWV
I
4569.11
9.06
7
3
11
+2
2.57
-0.668
71.46
Mammalian: 1 hour Yeast: 30 min E.coli: >10 hour
1615
0.35
15
Residue Composition
number
2
A
4
R
5
N
1
D
2
C
2
E
1
Q
4
G
2
H
7
I
0
L
1
K
0
M
1
F
2
P
2
S
4
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 2 R: 4 N: 5 D: 1 C: 2 E: 2 Q: 1 G: 4 H: 2 I: 7 L: 0 K: 1 M: 0 F: 1 P: 2 S: 2 T: 4 W: 0 Y: 1 V: 0
Chemical Descriptors
41 reviewed residue count
C193H312N64O61S2 sequence-only estimate (linear, free termini)
4569.11 sequence-only estimate (linear, free termini)
9.06 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
2.57 sequence-only estimate (linear, free termini)
-0.668 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA